Product Information |
|
Registration Number |
DR-XY26134
|
Generic Name |
Fludarabine Phosphate
|
Brand Name |
Fludara
|
Dosage Strength |
50mg
|
Dosage Form |
Powder For Injection (IV)
|
Classification |
Prescription Drug (Rx)
|
Packaging |
Type I Clear glass vial (Box of 5's)
|
Pharmacologic Category |
-
|
Manufacturer |
Baxter Oncology GmbH
|
Country of Origin |
switzerland
|
Trader |
N/A
|
Importer |
N/A
|
Distributor |
N/A
|
Application Type |
Initial (from Monitored Release)
|
Issuance Date |
26 October 2022
|
Expiry Date |
05 May 2025
|